- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05569837
The Effect of Irregular Meal Pattern Providing Hypo-energetic Diet on Energy Expenditure and Metabolism
The Effect of Irregular Meal Pattern Providing Hypo-energetic Diet on Energy Expenditure, Metabolism and Circadian Rhythm: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Experimental protocol:
28 women who are a healthy weight or overweight (aged 18-45 years) will be recruited to a randomized parallel trial to follow one of two 14-d hypo-energetic diets. Firstly, participants will consume a diet providing their estimated energy requirement (6 meals/day) for a 7 day standardisation period. After a one day laboratory visit, this will be followed by a 14 day intervention period when participants will follow a regular meal pattern (6 meals/d) or an irregular meal pattern (3-9 meals/d) (energy deficit of 800kcal/ 24h in both diets) (identical foods provided on both interventions whilst otherwise free living). Following a further laboratory visit day, they will then consume the previous standardisation diet providing their estimated energy requirement (6 meals/day) for a further 3 days. All foods to be consumed during the study will be provided to free of charge. These will comprise foods commonly consumed in the British diet and will be consumed in amounts designed to provide 800kcal/24h less than estimated energy requirements in the intervention period. Participants will attend the laboratory visits fasting and a blood sample will be obtained for fasting glucose, insulin and lipids. A test drink will then be given and over the following three hours measurements will be taken of energy expenditure (TEF). An ad libitum pasta test meal will be offered three hours after the test drink has been given. Subjective appetite ratings will be assessed while fasting, after the test drink, after the ad libitum meal, and during the intervention. Continuous interstitial glucose monitoring will be undertaken throughout the study. Ambulatory activity pattern measurement will be assessed in the intervention period. Core body temperature will be measured during the last 3 days of the first standardisation period, and during the final three standardisation days. Peripheral body temperature will be measured throughout the study period using a small i- button secured to the wrist. The study will commence at the early phase of the menstrual cycle (days1-7). A constant sleep-wake (and light exposure) routine will be followed for the whole study period which will be assessed by a written questionnaire form
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, United Kingdom, NG7 2RD
- The University of Nottingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI between 18.5 and 30 kg/m2,
- Age between 18 and 45y,
- Non-smokers,
- Non high-alcohol consumers (≥ 14 units/week),
- Regular menstruation or on the oral contraceptive pills,
- Their weight is stable during the previous 3 months,
- No self-reported history of serious medical conditions and not under medication.
Exclusion Criteria:
- Pregnant or lactating women
- Smokers
- High-alcohol consumers (≥ 14 units/week)
- Subjects with high score for depression using Becks Depression Inventory
- subjects Eating Attitudes Test (EAT-26) score >20
- Subjects who on diet or seeking to lose weight
- Subjects with high consumption of coffee or tea > 3 cups/day
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Regular meal pattern
Participants will follow a regular meal pattern for 14 days
|
6 meals every day
|
|
EXPERIMENTAL: Irregular meal pattern
Participants will follow an irregular meal pattern for 14 days
|
It consists of consuming a different number of meals every day (between 3 and 9).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline thermic effect of food in kcal at 2 weeks intervention
Time Frame: Over 3 hours for 2 days
|
Indirect calorimetry (GEM system; Europa Scientific Ltd.) will be used to determine the resting energy expenditure (REE) and thermic effect of food (TEF).
REE will be measured in the fasted state for 20 min.
The TEF will be measured for periods of 15 min at 30-min intervals during the 3 h after test drink (milkshake) consumption.
|
Over 3 hours for 2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline body Weight in kilograms at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
Body weight
|
1 day before intervention and 1 day after intervention
|
|
Change in subjective appetite
Time Frame: 2 days in lab visit, 1 day pre-intervention standardization period, 1 day post-intervention standardization period and 2 days in intervention period
|
a booklet will be given to record the subjective appetite (hunger, fullness and desire to eat) using visual analogue scales (VAS) before and after each single meal on:
|
2 days in lab visit, 1 day pre-intervention standardization period, 1 day post-intervention standardization period and 2 days in intervention period
|
|
Continuous interstitial glucose
Time Frame: 26 days
|
Continuous interstitial glucose will be undertaken using a continuous glucose monitor (CGM) the FreeStyle Libre System during the whole study period
|
26 days
|
|
Change from baseline fasting glucose in mmol/L at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum glucose
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline fasting insulin in mlU/L at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum insulin
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline fasting lipids in mmol/L at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum total cholesterol, HDL cholesterol, LDL cholesterol and triacylglycerol.
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline fasting glucagon-like peptide1 in pM at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma glucagon-like peptide1(GLP-1).
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline fasting peptide YY in pg/ml at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma peptide YY (PYY).
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline fasting ghrelin in pg/ml at 2 weeks intervention
Time Frame: 1 day before intervention and 1 day after intervention
|
A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma ghrelin.
|
1 day before intervention and 1 day after intervention
|
|
Change from baseline core body temperature in Celsius at 2 weeks intervention
Time Frame: 3 days in pre and post intervention
|
Core temperature will be assessed using an ingestible telemetry pill and associated monitor (e-Celsius Performance pill and monitor e-Celcius™ BodyCap).
|
3 days in pre and post intervention
|
|
Peripheral wrist temperature in Celsius
Time Frame: 26 days
|
Wrist temperature will be assessed through a wireless iButton data logger
|
26 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Alhussain MH, Macdonald IA, Taylor MA. Irregular meal-pattern effects on energy expenditure, metabolism, and appetite regulation: a randomized controlled trial in healthy normal-weight women. Am J Clin Nutr. 2016 Jul;104(1):21-32. doi: 10.3945/ajcn.115.125401. Epub 2016 Jun 15.
- Farshchi HR, Taylor MA, Macdonald IA. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr. 2004 Jul;58(7):1071-7. doi: 10.1038/sj.ejcn.1601935.
- Farshchi HR, Taylor MA, Macdonald IA. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. Int J Obes Relat Metab Disord. 2004 May;28(5):653-60. doi: 10.1038/sj.ijo.0802616.
- Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24. doi: 10.1093/ajcn/81.1.16.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 473- 2001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Regular meal pattern
-
University of NottinghamCompletedNitrogen BalanceUnited Kingdom
-
University of NottinghamCompleted
-
Purdue UniversityCompletedBioavailability | Dietary Modification | Carotenoid
-
Purdue UniversityDairy Research Institute; National Cattlemen's Beef Association; American Egg... and other collaboratorsCompletedParesis | Body Composition, Beneficial | Impaired Glucose ToleranceUnited States
-
University of NottinghamCompletedObesity | Metabolic SyndromeUnited Kingdom
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolCompletedHealthy | Sleep | Exercise | Dietary Intervention | Nutrition | Glycemic VariabilityPortugal
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolRecruitingHealthy Participants | Endurance Exercise | Substrate MetabolismPortugal
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Federação Portuguesa de FutebolCompletedHealthy | Craving | Postprandial Hyperglycemia | Nutrition, Healthy | HungerPortugal
-
Chiang Mai UniversityWithdrawnGynecologic NeoplasmsThailand
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.CompletedHead and Neck CancerUnited States